GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Spring Pharmaceutical Group Inc (OTCPK:CYIG) » Definitions » ROCE %

Spring Pharmaceutical Group (Spring Pharmaceutical Group) ROCE % : 5.33% (As of Mar. 2019)


View and export this data going back to . Start your Free Trial

What is Spring Pharmaceutical Group ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Spring Pharmaceutical Group's annualized ROCE % for the quarter that ended in Mar. 2019 was 5.33%.

Spring Pharmaceutical Group ROCE % Historical Data

The historical data trend for Spring Pharmaceutical Group's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Spring Pharmaceutical Group ROCE % Chart

Spring Pharmaceutical Group Annual Data
Trend Mar10 Mar11 Mar12 Mar13 Mar14 Mar15 Mar16 Mar17 Mar18 Mar19
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16.64 15.85 16.92 15.49 17.14

Spring Pharmaceutical Group Quarterly Data
Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.03 22.76 20.77 21.62 5.33

Spring Pharmaceutical Group ROCE % Calculation

Spring Pharmaceutical Group's annualized ROCE % for the fiscal year that ended in Mar. 2019 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2019 )  (A: Mar. 2018 )(A: Mar. 2019 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2019 )  (A: Mar. 2018 )(A: Mar. 2019 )
=19.148/( ( (110.138 - 1.983) + (115.948 - 0.64) )/ 2 )
=19.148/( (108.155+115.308)/ 2 )
=19.148/111.7315
=17.14 %

Spring Pharmaceutical Group's ROCE % of for the quarter that ended in Mar. 2019 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2019 )  (Q: Dec. 2018 )(Q: Mar. 2019 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2019 )  (Q: Dec. 2018 )(Q: Mar. 2019 )
=6.056/( ( (114.301 - 2.181) + (115.948 - 0.64) )/ 2 )
=6.056/( ( 112.12 + 115.308 )/ 2 )
=6.056/113.714
=5.33 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2019) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Spring Pharmaceutical Group  (OTCPK:CYIG) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Spring Pharmaceutical Group ROCE % Related Terms

Thank you for viewing the detailed overview of Spring Pharmaceutical Group's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Spring Pharmaceutical Group (Spring Pharmaceutical Group) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Spring Pharmaceutical Group Inc (OTCPK:CYIG) » Definitions » ROCE %
Comparable Companies
ASX:AZT BOM:524711 BOM:530233 INNV WAR:CBD CXUS BOM:524202 XCNQ:VENI NSE:PAR BOM:540694 FRA:ELN OSTO:GABA XSAT:ACUC XCNQ:GSTR BUD:NUTEX MCOA ETST BOM:531726 XCNQ:RVV SGX:BFK
Traded in Other Exchanges
N/A
Address
No. 11, Quanxing Road, Sishui County, Shandong Province, Jinan, CHN, 273200
Website
http://www.sdctyy.cn
Spring Pharmaceutical Group Inc is a health care company. The company is engaged in the developing, manufacturing and selling innovative traditional Chinese medicines made from panax ginseng leaves extract, developing acer truncatum bunge planting, processing and selling acer truncatum bunge seed oils in the PRC. Some of its product includes Vitality Source Capsule (24 capsules); Vitality Source Capsules (36 capsules); Millet cattle drinking music and others.